Motion Granted; Appeal Dismissed and Memorandum Opinion filed December 28, 2023 In The Fourteenth Court of Appeals NO. 14-22-00882-CV NAVIDEA BIOPHARMACEUTICALS, INC. AND MACROPHAGE THERAPEUTICS, INC., Appellants V. CAPITAL ROYALTY PARTNERS II, L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND “A”, L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS, II, L.P.; CAPITAL ROYALTY PARTNERS II (CAYMAN) L.P.; CR GROUP, L.P.; CRG SERVICING, LLC; AND CAPITAL ROYALTY PARTNERS II – PARALLEL FUND “B” (CAYMAN) L.P., Appellees On Appeal from the 151st District Court Harris County, Texas Trial Court Cause No. 2018-24442 MEMORANDUM OPINION This is an appeal from a judgment signed September 1, 2022. On December 6, 2023, appellants filed an agreed motion to dismiss the appeal. See Tex. R. App. P. 42.1. The motion is granted. Costs are taxed against the party incurring such costs. We dismiss the appeal. PER CURIAM Panel consists of Justices Bourliot, Zimmerer and Spain. 2